Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Bacterial Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01589185
What this trial is testing

Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)

Who this might be right for
Pneumonia Due to Staphylococcus Aureus
Aridis Pharmaceuticals, Inc. 48
Not applicableLooking for participantsNCT06618989
What this trial is testing

Diagnostic Performance of a Combination of Leukocyte Cell Surface Markers in Predicting the Risk of Severe Bacterial Infection in Febrile Children Under Three Months of Age in the Emergency Department: a Pilot Study.

Who this might be right for
Children Under 3 Months of Age With Fever
Assistance Publique - Hôpitaux de Paris 180
Not applicableLooking for participantsNCT06707246
What this trial is testing

Trial Comparing the Efficacy and Safety of Secukinumab with Tofacitinib in the Treatment of Moderate to Severe Hidradenitis Suppurativa in Chinese Patients

Who this might be right for
Hidradenitis Suppurativa
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Not applicableActive Not RecruitingNCT06517732
What this trial is testing

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 107
Not applicableStudy completedNCT01867905
What this trial is testing

Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock

Who this might be right for
Severe SepsisSeptic ShockBacteremia
University of British Columbia 330
Not applicableLooking for participantsNCT05993442
What this trial is testing

Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.

Who this might be right for
Infection, BacterialInfection Prevention
PENTA Foundation 3,080
Not applicableStudy completedNCT02303587
What this trial is testing

Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP)

Who this might be right for
Mycoplasma Pneumoniae Pneumonia
Beijing Children's Hospital 424
Large-scale testing (Phase 3)Active Not RecruitingNCT06468228
What this trial is testing

Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
AbbVie 1,400
Large-scale testing (Phase 3)Study completedNCT02904902
What this trial is testing

Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
AbbVie 15
Not applicableLooking for participantsNCT07543419
What this trial is testing

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 250
Post-approval studies (Phase 4)Study completedNCT07708480
What this trial is testing

Comparative Efficacy of Apremilast and Acitretin in Moderate-to-Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
Hayat Abad Medical Complex, Peshawar 70
Testing effectiveness (Phase 2)Study completedNCT01794182
What this trial is testing

Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals

Who this might be right for
Ischemic StrokeMalignant Edema
Remedy Pharmaceuticals, Inc. 86
Post-approval studies (Phase 4)Ended earlyNCT02283905
What this trial is testing

Amphotericin-B and Voriconazole for Pulmonary Blastomycosis

Who this might be right for
Blastomycosis
University of Manitoba 2
Not applicableNot Yet RecruitingNCT07690319
What this trial is testing

Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 186
Not applicableUnknownNCT03156972
What this trial is testing

Speckle Tracking for Timing of Surgical Operation in Severe Mitral Regurge

Who this might be right for
Rheumatic Heart Disease
Mohammed mahmoud mohammed othman 30
Post-approval studies (Phase 4)Study completedNCT02808975
What this trial is testing

Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically

Who this might be right for
Hidradenitis Suppurativa (HS)
AbbVie 206
Not applicableUnknownNCT01628744
What this trial is testing

Autoantibodies Against Specific Cytokines in Adults With Severe Mycobacterial Infection

Who this might be right for
Mycobacterium Infection
China Medical University Hospital 100
Early research (Phase 1)Study completedNCT05220605
What this trial is testing

Nebulised BromAc in Healthy Volunteers

Who this might be right for
COVID-19 PneumoniaBromelains Adverse ReactionAcetylcysteine Adverse Reaction+2 more
Mucpharm Pty Ltd 12
Large-scale testing (Phase 3)Study completedNCT04242498
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
UCB Biopharma SRL 509
Large-scale testing (Phase 3)Looking for participantsNCT05645107
What this trial is testing

Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Who this might be right for
HypogammaglobulinemiaBacterial InfectionsB-cell Chronic Lymphocytic Leukemia+2 more
Grifols Therapeutics LLC 386
Next Page